Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Palliative and end-of-life care from an education lens. An international systematic review of undergraduate medical and nursing students' knowledge, perceptions, and orientation towards palliative and end-of-life care.

Palliative care and social practice·2026

Same author

Final-year undergraduate nursing and medical students' knowledge, perception, orientation and perceived self-efficacy to provide palliative and end-of-life care: Qualitative findings from a parallel mixed-methods study.

Palliative care and social practice·2026

Same author

Investigating phototoxicity of optical coherence tomography imaging in porcine and human spermatozoa.

Reproductive biomedicine online·2025

Same author

Characterization of Novel Luteoviruses in Canadian Highbush Blueberries Using High-Throughput Sequencing.

Viruses·2025

Same author

Universal preimplantation genetic testing for monogenic disease (Karyomapping): diagnosis of >1000 unique disorders with no detected misdiagnoses.

Human reproduction (Oxford, England)·2025

Same author

Exploring Nursing and Medical Students' Experiences of Handling Challenging Conversations: A Qualitative Focus Group Study.

Advances in medical education and practice·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Drug development: from concept to marketing!

Nihad A M Tamimi¹, Peter Ellis

¹Pfizer Inc., Sandwich, UK. tamimis@gmail.com

Nephron. Clinical Practice

|September 5, 2009

Summary

Drug development is a lengthy, costly, and high-risk process, with only about 1 in 10 drugs reaching the market. Rigorous pre-clinical and clinical testing ensures drug safety and efficacy for regulatory approval.

Area of Science:

Pharmaceutical Sciences
Drug Discovery and Development
Regulatory Affairs

Background:

Drug development is a complex, lengthy (10-15 years), and high-risk endeavor with a significant attrition rate.
The process is driven by medical need, disease prevalence, and the probability of successful outcomes.
Candidate selection involves iterative chemistry and biology refinement, with only ~0.1% of synthesized compounds progressing to clinical trials.

Purpose of the Study:

To outline the multifaceted stages and challenges inherent in the drug development pipeline.
To highlight the critical role of pre-clinical and clinical testing in ensuring drug safety and efficacy.
To emphasize the stringent regulatory standards governing pharmaceutical product approval and post-marketing surveillance.

Main Methods:

More Related Videos

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Related Experiment Videos

Last Updated: Jun 20, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Pre-clinical testing involves extensive in vitro and in vivo studies, including animal testing for pharmacology, biochemistry, safety, carcinogenicity, and reproductive effects.
Clinical development comprises Phase I (healthy volunteers: pharmacokinetics, safety, toleration), Phase II (patients: efficacy, dose-response), and Phase III (large-scale: safety, efficacy confirmation).
Post-marketing surveillance monitors adverse events to ensure continued product safety after market approval.

Main Results:

Approximately 1 in 1,000 synthesized compounds enters pre-clinical testing.
Only about 1 in 10 drugs entering clinical trials ultimately reach the market.
Successful drug approval requires demonstrating a favorable benefit-risk profile in the target patient population.

Conclusions:

Drug development necessitates a rigorous, multi-stage process governed by strict regulatory standards.
Ensuring drug safety and efficacy through comprehensive pre-clinical and clinical evaluation is paramount.
Continuous post-approval monitoring is essential for long-term patient safety and therapeutic benefit.